Showing posts with the label AbbVie

VENCLEXTA® (venetoclax) Receives FDA Full Approval for Acute Myeloid Leukemia (AML)

AbbVie announced that the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA® (venetoclax) in combination with azacitidine, or decitabine, or low-dose cytarabine (LDAC) f…

Allergan Aesthetics Acquires Innovative Luminera Dermal Filler Business

Allergan Aesthetics, an AbbVie company announced that it has entered into an agreement with Luminera, a privately held, aesthetics company based in Israel with a portfolio and pipeline of dermal fill…
Subscribe Our Newsletter